Kido-Nakahara Makiko, Furue Masutaka, Ulzii Dugarmaa, Nakahara Takeshi
Department of Dermatology, Kyushu University, Maidashi 3-1-1, Higashiku, Fukuoka 812-8582, Japan.
Department of Dermatology, Kyushu University, Maidashi 3-1-1, Higashiku, Fukuoka 812-8582, Japan.
Immunol Allergy Clin North Am. 2017 Feb;37(1):113-122. doi: 10.1016/j.iac.2016.08.007. Epub 2016 Nov 1.
Chronic itch in inflammatory skin diseases, such as atopic dermatitis, markedly diminishes the quality of life of affected individuals. Comprehensive progress has been made in understanding itch signaling and associated mediators in the skin, dorsal root ganglia, spinal cord, and central nervous system, which may amplify or suppress atopic itch. Conventional therapies for atopic dermatitis are capable of reducing atopic itch; however, most patients are not satisfied with the antipruritic capacity of conventional treatments. Exploring itch pathways and mechanisms may lead to novel therapeutic approaches for atopic itch.
在特应性皮炎等炎症性皮肤病中,慢性瘙痒会显著降低患者的生活质量。在理解皮肤、背根神经节、脊髓和中枢神经系统中的瘙痒信号及相关介质方面已取得了全面进展,这些信号和介质可能会放大或抑制特应性瘙痒。特应性皮炎的传统疗法能够减轻特应性瘙痒;然而,大多数患者对传统治疗的止痒能力并不满意。探索瘙痒途径和机制可能会带来治疗特应性瘙痒的新方法。